Drawing for SELINCRO NALMEFENE

USPTO serial 79139500

SELINCRO NALMEFENE

Reviewed by CopyMark Law Group

Reg. 4709949Status 404
Filing date
Status date
Registration date
Mar 31, 2015
Examiner
POWERS, ALEXANDER L
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with SELINCRO NALMEFENE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Claudia A. Smith

Claudia A. Smith White & Case LLP1155 Avenue of the AmericasPatent and Trademark DepartmentNew York, NY 10036

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases, generated by or acting on the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; pharmaceutical preparations and substances for the prevention and treatment of Alzheimer's disease and disorder, depression, psychosis, anxiety, epilepsy, multiple sclerosis, porphyria, Huntington's disease and disorder, insomnia, Parkinson's disease and disorder, schizophrenia, bipolar disorder and disease, oncology, pain, alcohol dependency; vaccines; medicinal preparations for the treatment of central nervous system diseases and disorders and diagnostic preparations for medical purposes, all of the foregoing containing in whole or substantial part nalmefeneSECTION 71 - CANCELLED—
009Downloadable electronic publications, namely, books, reports, brochures, booklets, leaflets, patient information leaflets, magazines, journals, teaching and educational material in the field of research and development, science, clinical tests, diagnostics, medicine, pharmaceuticals, disorders, diseases, treatment and prevention; data processing equipment and computers; computer hardware and software for information and information management for use of a web-based physical and psychological and neurological examination and assessment of patients and clients at a distance and at a clinic; application software for mobile devices, namely, applications with customized information regarding medicine dosage, medical diagnosis, therapy and medical information regarding central nervous system diseases and disorders; downloadable electronic publications in the nature of manuals in the field of central nervous system diseases and disordersSECTION 71 - CANCELLED—
010Medical test kits for the treatment and study of alcohol dependency; medical instruments and apparatus for the treatment and study of alcohol dependencySECTION 71 - CANCELLED—
016Printed instructional, educational and teaching materials in the field of research regarding depression; publications, namely, books, reports, brochures, booklets, leaflets, patient information leaflets, magazines, journals, teaching and educational material in the field of research and development of central nervous system diseases and disorders and pharmaceuticals for the treatment and prevention of depression, medical science, clinical tests, diagnostics of central nervous system diseases and disorders, medicine, pharmaceuticals for the treatment of central nervous system diseases and disorders and the treatment and prevention of depression and central nervous system disorders and diseasesSECTION 71 - CANCELLED—
035Retail and wholesale store services featuring pharmaceuticals; promotion and advertising services in the field of research and development, science, clinical tests, diagnostics, medicine, pharmaceuticals, disorders, diseases, treatments and prevention; provision of the aforementioned services on-line, via cable or Internet or other electronic mediaSECTION 71 - CANCELLED—
041Arranging and conducting educational seminars, conferences, symposiums, training workshops and courses; educational and training services in the form of educational seminars, conferences, symposia, education workshops and courses in the field of research and development, science, clinical tests, diagnostics, medicine, pharmaceuticals, disorders, diseases, treatments and prevention; educational and training services in the field of research and development, science, clinical tests, diagnostics, medicine, pharmaceuticals, disorders, diseases, treatments and prevention provided electronically, on-line, via cable or Internet or other electronic media; arranging and conducting of on-line educational forums, in the form of educational seminars, conferences, symposia, education workshops and courses; on-line training programs in the field of pharmaceutical research and development; providing non-downloadable on-line publications, namely, of books, reports, brochures, booklets, leaflets, patient information leaflets, magazines, journals, teaching and educational material in the field of research and development, science, clinical tests, diagnostics, medicine, pharmaceuticals, disorders, diseases, treatments and prevention; on-line publication of medical data and analysis reports designed to provide patients and clients customized information, namely, medical dose, diagnosis, therapeutic issues and medical administrationSECTION 71 - CANCELLED—
042Providing on-line non-downloadable software for pharmaceutical research and development; scientific and technological research in the field of central nervous system disorders, diseases and the prevention thereof; medical research and tests; clinical research and tests; diagnostic research in the field of alcohol dependency; providing research and development services in the fields of medicine, science and clinical testingSECTION 71 - CANCELLED—
044Medical services; medical clinical services; medical treatment services; therapeutic treatment services; healthcare and medical services all related to central nervous system disorders, diseases and pharmaceuticals for the treatment thereof; providing medical and medicinal information in the field of diagnosis, medicine, pharmaceuticals, disorders, diseases, treatments and prevention; medical information services; diagnostic tests all in the field of central nervous system diseases and disordersSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 30, 2023DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
Oct 30, 2023DETHDEATH OF INTERNATIONAL REGISTRATION—
Sep 26, 2022INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Sep 1, 2022INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Sep 1, 2022INPCINVALIDATION PROCESSED—
Jul 26, 2022INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Nov 26, 2021C71TCANCELLED SECTION 71—
Mar 31, 2020REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Aug 28, 2015FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Aug 11, 2015FICSFINAL DISPOSITION NOTICE SENT TO IB—
Aug 11, 2015FIMPFINAL DISPOSITION PROCESSED—
Jun 30, 2015FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Mar 31, 2015R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 15, 2015GPNXNOTIFICATION PROCESSED BY IB—
Jan 13, 2015NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 13, 2015PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 24, 2014OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Dec 24, 2014OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Dec 24, 2014NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 6, 2014PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Dec 5, 2014CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 5, 2014XAECEXAMINER'S AMENDMENT ENTERED—
Dec 5, 2014GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Dec 5, 2014GNEAEXAMINERS AMENDMENT E-MAILED—
Dec 5, 2014CNEAEXAMINERS AMENDMENT -WRITTEN—
Dec 5, 2014XAECEXAMINER'S AMENDMENT ENTERED—
Dec 5, 2014GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Dec 5, 2014GNEAEXAMINERS AMENDMENT E-MAILED—
Dec 5, 2014CNEAEXAMINERS AMENDMENT -WRITTEN—
Jul 28, 2014GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 28, 2014GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 28, 2014CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 28, 2014ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Jun 13, 2014PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Jun 12, 2014ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 12, 2014REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
May 31, 2014PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
May 31, 2014CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 24, 2014TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 24, 2014CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 15, 2014ALIEASSIGNED TO LIE—
May 3, 2014TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 6, 2014RFNTREFUSAL PROCESSED BY IB—
Dec 17, 2013MAFRAPPLICATION FILING RECEIPT MAILED—
Dec 13, 2013RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Dec 13, 2013RFRRREFUSAL PROCESSED BY MPU—
Dec 13, 2013RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Dec 12, 2013CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 11, 2013DOCKASSIGNED TO EXAMINER—
Dec 11, 2013NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 9, 2013LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Dec 6, 2013REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance